IL-10 production by B-cells during MS relapses is modulated through the interplay between TLR4 and CD40 signaling, implying that CD40 potentially contributes to recovery from MS relapse if signaling takes place concurrently with TLR4 [199]. The gene discussed is CD40; the disease is myeloid sarcoma.